The Krebs cycle occurs in the mitochondrial matrix, the gel-like compartment enclosed by the inner mitochondrial membrane. Every matrix enzyme that runs the cycle sits in that space, and the electron carriers it produces feed directly into the membrane-embedded electron transport chain. The cycle is the second stage of cellular respiration, after glycolysis in the cytosol, and it makes both ATP and the reduced coenzymes that drive most aerobic energy production in eukaryotic cells.
Matrix chemistry and the eight steps that define the cycle
The mitochondrial matrix is not a passive bag. It holds a protein concentration of roughly 270–300 grams per liter, a magnesium content of about 10–15 millimoles per liter, and a pH near 7.8. Pyruvate dehydrogenase, citrate synthase, isocitrate dehydrogenase, and the rest of the cycle's eight enzymes all work in that environment. The enzymes sit near the inner membrane or float free in the matrix space, close enough that the NADH and FADH2 they release can dock with complex I and complex II within milliseconds.
The cycle begins when acetyl-CoA, a two-carbon unit made from pyruvate in the matrix, condenses with the four-carbon oxaloacetate. Citrate synthase catalyzes that step and pulls the reaction forward, which keeps oxaloacetate concentration extremely low. The enzyme's affinity for oxaloacetate is tight enough that the condensation becomes essentially irreversible under physiological conditions. The result is citrate, a six-carbon molecule that is then converted step by step back to oxaloacetate.
One turn releases two molecules of carbon dioxide, one ATP or GTP, three NADH, and one FADH2. Each pair of carbons entering as acetyl-CoA leaves as CO2, so the carbon count never accumulates. The cycle is catalytic, not consumptive: oxaloacetate is regenerated and only needs a trace supply to turn over.
The inner mitochondrial membrane is the real boundary. It is impermeable to most small charged molecules, so NADH made in the matrix cannot leave. Electrons must pass through shuttles or redox carriers. The membrane is a second, tighter compartment inside the outer membrane's wider one, creating the proton gradient that powers ATP synthase. That architecture matters because the cycle's output is judged not by carbon balance but by how many reducing equivalents it hands to the chain.
A professional caveat: textbook diagrams draw the cycle as a closed loop, but real cells operate it as a branched pool. Intermediates such as citrate, succinate, and alpha-ketoglutarate are siphoned off for lipid synthesis, heme production, and amino acid metabolism. Unless the cell replenishes oxaloacetate through anaplerosis from pyruvate or glutamate, running the cycle for fuel drains it. This purloining is why the cycle cannot run at peak throughput indefinitely on a depleted pool.
How much energy one turn produces, and what limits it
Acetyl-CoA oxidation yields roughly 10 to 12 ATP equivalents per molecule when the full electron transport chain is coupling. Three NADH feed complex I, each contributing about 2.5 ATP. The single FADH2 enters at complex II and yields about 1.5 ATP because it bypasses complex I. One substrate-level phosphorylation adds 1 ATP or GTP directly. That arithmetic lands near 10 ATP for most tissues and 11 or 12 in cells where GTP is converted to ATP efficiently.
The limiting factor is rarely acetyl-CoA supply. It is usually oxygen or NAD+ availability. When oxygen falls, NADH accumulates and the cycle slows because the dehydrogenase reactions need NAD+ as an electron acceptor. This is why the cycle is often called oxygen-dependent despite none of its enzymes consuming oxygen directly. The chain consumes the oxygen, and the cycle runs downstream of the chain's function.
Rate is set by three regulatory enzymes: citrate synthase, isocitrate dehydrogenase, and alpha-ketoglutarate dehydrogenase. Isocitrate dehydrogenase responds both to ADP and to NADH. When ADP rises, the enzyme accelerates. When NADH rises, it slows. This dual control links cycle throughput to ATP demand. The cycle turns faster when the cell needs energy and eases off when ATP is plentiful.
Quantify the scale. A typical adult at rest oxidizes roughly 200–300 grams of glucose per day and a comparable amount of fat. That flux drives an estimated turnover of trillions of acetyl-CoA molecules per second across all mitochondria. The heart, which never rests, runs high cycle flux continuously and consumes about 20 percent of the body's oxygen. The cycle does not flame out; it hums at a steady rate tuned to the organ's demand.
The counterintuitive detail: the cycle is often described as producing energy, but its central job is anabolism as much as catabolism. Citrate export feeds fatty acid and cholesterol synthesis. Alpha-ketoglutarate is a nitrogen sink for amino acid transamination. Succinyl-CoA is a precursor for heme. About one fifth of the cycle's outgoing carbon flux in some tissues is diverted to building material rather than burned.
Anaerobic edge cases, facultative tissues, and cells without mitochondria
Not every human cell uses a mitochondria-heavy strategy. Mature red blood cells discard their mitochondria during differentiation and rely entirely on glycolysis. Sperm cells hold a mitochondrial sheath in the midpiece to power the flagellum. Eye lens fibers and the outer layers of skin are metabolically hyperglycolytic and tolerate low cycle activity.
At the tissue scale, the issue is ischemia rather than anatomy. In a blocked coronary artery, the affected myocardium loses oxygen within seconds. NADH accumulates, the cycle stalls, and cells shift to anaerobic glycolysis for ATP. The proton motive force collapses as the chain stops pumping protons. This is the biochemical reason oxygen deprivation damages tissue within minutes, not hours.
A seemingly paradoxical observation: some cells with functional mitochondria run glycolysis at high rates anyway. Tumor cells often exhibit the Warburg effect, fermenting glucose to lactate even in aerobic conditions. The cycle is present and active but shifts its products toward biosynthesis. A clinician reading a PET scan is watching glucose uptake, not cycle oxidation directly. The two are not interchangeable measurements.
Species that lack mitochondria entirely exist, such as certain anaerobic eukaryotes, but they are not part of normal human physiology. For human biology, the practical rule holds: any cell that runs an oxidative metabolism has a matrix, and that matrix is where the cycle occurs. The only true absence is in cells that discarded mitochondria or store few of them under stress.
Misconceptions that disguise the real site
Misconception one: the Krebs cycle occurs in the cytosol. That is wrong for human cells. Glycolysis happens in the cytosol and exports pyruvate to the matrix, but the eight-cycle machinery is mitochondrial. The confusion arises because bacteria run a related cycle in their cytosol; eukaryotes compartmentalized it.
Misconception two: the electron transport chain is part of the cycle. It is not. The chain sits in the inner mitochondrial membrane, and the cycle sits in the matrix. They are adjacent, not the same system. Mapping them as one unit makes the anatomy fuzzy and leads to misplaced drug targets.
Misconception three: the cycle consumes oxygen. It does not consume oxygen directly; it passes electrons to NAD+ and FAD. Oxygen is the terminal acceptor in the following stage. You can run the cycle in a sealed sample for a short burst until NADH builds up, then it stops.
Misconception four: the cycle is the only source of NADH. Beta-oxidation in the matrix and glycolysis in the cytosol both feed reducing equivalents into the chain through shuttles. An athlete burning fat is running beta-oxidation harder than the cycle per unit time.
A student who pairs the Krebs cycle with the cytosol has likely confused ATP production with glycolysis and should redraw the compartment map. A clinician ordering a mitochondrial myopathy evaluation should remember that isolated cycle defects often present with specific chemical signatures, not generalized fatigue alone. A reader of popular diet claims should distrust claims that vegetables "feed the cycle" without evidence; the formatting is often rhetorical. Someone learning cellular bioenergetics should confirm where NADH is generated before attributing energy loss to the cycle.
Practical actions: studying, interpreting, and testing the cycle
Pull up a labeled mitochondrial diagram and place a sticky note on the matrix. Practice naming each enzyme and its compartment until it is automatic. Use published images from a major society or established textbook, not memes.
Build a one-page compartment list: glycolysis (cytosol), pyruvate oxidation (matrix), Krebs cycle (matrix), electron transport chain (inner membrane), oxidative phosphorylation (inner membrane and matrix). Compare against it when readings get muddled.
Anchor numbers. The cycle yields about 10 ATP equivalents per acetyl-CoA, three NADH, one FADH2, and one direct ATP or GTP. These figures set up the rest of the exam question schema and the reading of bioenergetics papers.
Watch for changes in how the cycle flux is reported. When a laboratory reports a decreased "Krebs cycle" activity, confirm which enzyme and which tissue were measured. Succinate dehydrogenase doubles as complex II and its location on the inner membrane means its assays differ from those of matrix-soluble enzymes.
Reconcile thresholds: a decrease in citrate synthase activity of about 20–30 percent in skeletal muscle can occur with normal function in some assays, while larger reductions usually warrant a genetics evaluation. That is educational context, not a diagnostic cutoff.
For clinical or research questions about specific measurements or suspected mitochondrial disease, defer to a genetics or metabolic specialist. The compartment map is broadly stable, but tissue-specific rates and test sensitivities are not one universal number.
Limitations of the simple picture
The "matrix" answer is correct but simplified. Mitochondria are dynamic; they fuse, divide, and move through the cell. In neurons, mitochondria are trafficked to synapses where ATP demand is highest. The cycle therefore occurs in specific physical locations within a cell, not uniformly across it.
Enzyme quantitation varies. Citrate synthase assays are sometimes used as a mitochondrial content marker rather than a cycle rate measure. High or low values can reflect organelle number rather than enzyme function. A single number without context misleads.
The distinction between compartments is at the center of understanding bioenergetics, but the human body is not a set of independent organelles. The cycle is one node in a metabolic network with shuttle systems, transporters, and feedback. Every simplification in a teaching article is a deliberate compression. The mechanism is stable; its quantitative parameters are tissue-specific and under measurement uncertainty. When this topic edges into diagnosing or treating a person, the question shifts from general knowledge to professional clinical judgment.
This article is general educational information about cellular localization and bioenergetics. It is not a diagnosis, treatment plan, or interpretation of an individual's laboratory results. For suspected mitochondrial disease or metabolic disorders, consult a qualified local physician or metabolic specialist; for immediate danger, contact local emergency or crisis services.